Rights and permissions
About this article
Cite this article
Carboplatin affords superior QOL vs cisplatin in NSCLC. Pharmacoecon. Outcomes News 446, 10 (2004). https://doi.org/10.2165/00151234-200404460-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404460-00025